INVESTMENT SECURITIES (Tables)

6 Months Ended

Jul. 31, 2020

Disclosure Investment Securities Tables Abstract

Schedule of Marketable Securities

On April 13, 2020, in conjunction with the reverse acquisition (see Notes 1 and 3), the Company recorded marketable securities as follows:

							Change in
							Fair Value
							For the Period
	Number						From April 13, 2020
	of		Fair Value at				through
	Shares		April 13, 2020		July 31, 2020		July 31, 2020
Common Shares of Entest Group, Inc. (ENTI)		66,667	$	367	$	260	$	(107	)
Common Shares of Regen Biopharma, Inc. (RGBP)		29,076,665		2,906		5,814		2,908
Series A Preferred Shares of Regen Biopharma, Inc. (RGBPP)		2,907,666		5,524		4,362		(1,162	)
Total			$	8,797	$	10,436	$	1,639